コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ystrophy, facioscapulohumeral dystrophy, and limb-girdle muscular dystrophy).
2 mains in dysferlin, whose gene is mutated in limb girdle muscular dystrophy.
3 lar dystrophy resembling what is observed in limb girdle muscular dystrophy.
4 protease calpain-3 cause autosomal recessive limb girdle muscular dystrophy.
5 -sarcoglycan-null (scgd(-/-)) mouse model of limb-girdle muscular dystrophy.
6 for delta-sarcoglycan (scgd-/-), a model of limb-girdle muscular dystrophy.
7 nale for the development of gene therapy for limb-girdle muscular dystrophy.
8 sarcolemma and produce one of four types of limb-girdle muscular dystrophy.
9 coglycan have been identified in humans with limb-girdle muscular dystrophy.
10 a, and delta) have been found in humans with limb-girdle muscular dystrophy.
11 ns lead to four forms of autosomal recessive limb-girdle muscular dystrophy.
12 mplex may be involved in the pathogenesis of limb-girdle muscular dystrophy.
13 rburg syndrome, to mild forms of adult-onset limb-girdle muscular dystrophy.
14 d its absence is common to both Duchenne and limb girdle muscular dystrophies.
15 stitute promising therapeutic strategies for limb-girdle muscular dystrophies.
16 l emphasis on animal models for Duchenne and limb-girdle muscular dystrophies.
17 tions in the encoding genes cause congenital/limb-girdle muscular dystrophies.
21 nsistent with the mild phenotype observed in Limb-girdle muscular dystrophy-1C (LGMD-1C) in humans, c
22 is of Cav-3-related muscle diseases, such as limb-girdle muscular dystrophy-1C, distal myopathy, and
28 tivity in a mouse model of the human disease limb girdle muscular dystrophy 2B (LGMD2B), caused by a
29 +) signaling offers a therapeutic avenue for limb girdle muscular dystrophy 2B and Miyoshi myopathy p
31 We have developed a new diagnostic assay for limb girdle muscular dystrophy 2B and Miyoshi myopathy,
32 EY POINTS: Dysferlin, the protein missing in limb girdle muscular dystrophy 2B and Miyoshi myopathy,
34 t mutations in dysferlin are responsible for limb girdle muscular dystrophy 2B and Miyoshi myopathy.
36 ssive muscular dystrophies Miyoshi myopathy, limb girdle muscular dystrophy 2B, and distal anterior c
39 ne resulting in dysferlin-deficiency lead to limb-girdle muscular dystrophy 2B and Myoshi myopathy in
40 ein dysferlin, underlie Miyoshi myopathy and limb-girdle muscular dystrophy 2B in humans and produce
48 emains unclear why mutations in Tcap lead to limb-girdle muscular dystrophy 2G (LGMD2G) in human pati
51 ngenital muscular dystrophy type 1C (MDC1C), limb girdle muscular dystrophy 2I (LGMD2I) and congenita
52 nerate a wide range of pathologies from mild limb girdle muscular dystrophy 2I (LGMD2I), severe conge
58 one of two previously identified disorders, limb-girdle muscular dystrophy 2L and non-dysferlin Miyo
59 various proteins known to be involved in the limb-girdle muscular dystrophies (alpha, beta, gamma, de
60 lly, we have identified an important case of limb girdle muscular dystrophy and cardiomyopathy with n
61 ng the pathogenesis of sarcoglycan deficient limb-girdle muscular dystrophies and for the development
63 ense mutation (Thr192-->Met) in a woman with limb-girdle muscular dystrophy and cognitive impairment.
64 emonstrate that FLN2 protein localization in limb-girdle muscular dystrophy and Duchenne muscular dys
65 anging from congenital muscular dystrophy to limb-girdle muscular dystrophy and identified allelic IS
66 tinct diseases, including three new forms of limb-girdle muscular dystrophy and one form of congenita
67 viral vectors have recently started, one in limb-girdle muscular dystrophy and one in Duchenne muscu
68 trophy (EDMD), dilated cardiomyopathy (DCM), limb-girdle muscular dystrophy, and Hutchison-Gilford pr
72 mma is dramatically reduced in patients with limb-girdle muscular dystrophy arising from the loss of
74 c hamster is a naturally occurring model for limb-girdle muscular dystrophy caused by a primary defic
75 models of muscular dystrophy, including DM1, limb-girdle muscular dystrophy, congenital merosin-defic
76 c conduction-system disease, and adult-onset limb-girdle muscular dystrophy (FDC, conduction disease,
78 abnormalities were not found, we identified limb-girdle muscular dystrophy gene mutations affecting
82 o sib pairs) with a predominantly late onset limb-girdle muscular dystrophy in whom an absence of mer
84 stroglycan causes an array of congenital and limb girdle muscular dystrophies known as dystroglycanop
88 pes including Walker-Warburg syndrome (WWS), limb girdle muscular dystrophy (LGMD) 2I and congenital
89 feature of four types of autosomal recessive limb girdle muscular dystrophy (LGMD) is that mutations
95 eneity which has long been recognized in the limb-girdle muscular dystrophies (LGMD) has been shown t
97 rcoglycan complex is known to be involved in limb-girdle muscular dystrophy (LGMD) and is composed of
99 s in POMT2 have also been linked to a milder limb-girdle muscular dystrophy (LGMD) phenotype, named L
100 ereditary inclusion body myopathy (hIBM) and limb-girdle muscular dystrophy (LGMD), are a genetically
103 dentified a novel autosomal dominant form of limb-girdle muscular dystrophy (LGMD-1C) in humans that
106 mple, in the diagnosis of autosomal dominant limb-girdle muscular dystrophy (LGMD1A), it is not alway
108 patients with sarcoglycanopathies, which are limb-girdle muscular dystrophies (LGMD2C-2F) caused by m
111 Another group of MD's referred to as the limb-girdle muscular dystrophies (LGMDs) can affect boys
115 ts presented as an adult or adolescent-onset limb-girdle muscular dystrophy, one presented with isola
116 rotein that may be a good candidate gene for limb-girdle muscular dystrophy or other neuromuscular di
117 nderlying the molecular mechanism of several limb-girdle muscular dystrophies, particularly those whe
119 e dystrophin-glycoprotein complex, produce a limb-girdle muscular dystrophy phenotype; however, the p
122 ption of the cardiac involvement in forms of limb girdle muscular dystrophies secondary to abnormal g
124 uscular dystrophies ranging from adult onset limb girdle muscular dystrophies to severe congenital fo
125 uscular dystrophies ranging from adult onset limb girdle muscular dystrophies to severe congenital fo
126 a broad spectrum of disorders, ranging from limb girdle muscular dystrophy to Walker-Warburg syndrom
128 The protein dysferlin, the product of the Limb Girdle Muscular Dystrophy type 2 locus, has been sh
132 enders patients deficient in calpain 3 as in limb girdle muscular dystrophy type 2A, albeit in a mild
133 akness was generally milder than observed in limb girdle muscular dystrophy type 2A, but affected the
139 ficiency of the dysferlin protein results in limb girdle muscular dystrophy type 2B and Miyoshi myopa
140 rlin, a member of the ferlin family, lead to limb girdle muscular dystrophy type 2B and Myoshi myopat
143 or several hereditary disorders that include limb girdle muscular dystrophy type 2H (LGMD2H), sarcotu
144 ed to two forms of muscular dystrophy called limb girdle muscular dystrophy type 2H and sarcotubular
146 Congenital muscular dystrophy type 1C and limb girdle muscular dystrophy type 2I are allelic, both
150 tations have been described in patients with limb-girdle muscular dystrophy type 1A (LGMD1A), myofibr
151 ery efforts for several disorders, including limb-girdle muscular dystrophy type 1A and the genes del
153 One such example recently discovered is limb-girdle muscular dystrophy type 1D (LGMD1D), which i
154 d calpain-3 (CAPN3) the product of the human limb-girdle muscular dystrophy type 2A (LGMD2A) gene.
156 the pathological signs in a murine model for limb-girdle muscular dystrophy type 2A after intramuscul
159 Genetic defects in calpain3 (CAPN3) lead to limb-girdle muscular dystrophy type 2A, a disease of the
162 been identified as a novel gene involved in limb-girdle muscular dystrophy type 2B (LGMD2B) and its
163 identified which is mutated in patients with limb-girdle muscular dystrophy type 2B (LGMD2B) and with
166 to two clinically distinct muscle diseases, limb-girdle muscular dystrophy type 2B and Miyoshi myopa
170 ssed gamma-sarcoglycan-null mice, a model of limb-girdle muscular dystrophy type 2C, with a Col6a2-de
172 Duchenne muscular dystrophy (DMD) patients, limb-girdle muscular dystrophy type 2D (LGMD2D) and thei
174 ults in a severe form of muscular dystrophy (limb-girdle muscular dystrophy type 2D [LGMD2D]) without
177 ide ligase-ubiquitin ligase mutated in human limb-girdle muscular dystrophy type 2H (LGMD2H) and Bard
179 RIM32) cause two seemingly diverse diseases: limb-girdle muscular dystrophy type 2H (LGMD2H) or sarco
180 letal muscle and is orthologous to the human limb-girdle muscular dystrophy type 2H disease gene Trim
181 nally, mutations in the FKRP gene also cause limb-girdle muscular dystrophy type 2I (LGMD2I), a consi
182 sociated with FKRP mutations range from mild limb-girdle muscular dystrophy type 2I with predominantl
183 alleles in biopsies of 6 patients, 3 with an limb-girdle muscular dystrophy type 2J (LGMD2J) phenotyp
184 ked to several clinical phenotypes including limb-girdle muscular dystrophy type 2L and Miyoshi myopa
186 lasting alpha-sarcoglycan gene expression in limb-girdle muscular dystrophy, type 2D (LGMD2D) subject
187 phy, facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophies types 2A and 2B, Miyosh
189 is observed in patients with other forms of limb-girdle muscular dystrophy where dystrophin and the
191 typic spectrum of GMPPB mutations to include limb-girdle muscular dystrophies with adult onset with o
192 mutations are responsible for congenital and limb-girdle muscular dystrophies with hypoglycosylation
194 e most severe form of dystroglycanopathy, to limb-girdle muscular dystrophy with cognitive defects.
195 e limited to patients with Duchenne-like and limb-girdle muscular dystrophy with normal dystrophin an
196 and structural eye defects to a mild form of limb-girdle muscular dystrophy with onset in adult life
197 the prevalence among patients with proximal (limb-girdle) muscular dystrophy with a later onset was 6
198 lities and intellectual delay to adult-onset limb-girdle muscular dystrophies without mental retardat
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。